STN: BL 101069
Proper Name: Measles, Mumps, and Rubella Virus Vaccine Live
Tradename: M-M-R II
Manufacturer: Merck, Sharp & Dohme Corp.
Indication:

• For active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.

Product Information

• Package Insert - Measles, Mumps, and Rubella Virus Vaccine Live
• Patient Package Insert - Measles, Mumps, and Rubella Virus Vaccine Live

Supporting Documents

• February 27, 2023 Approval Letter - Measles, Mumps, and Rubella Virus Vaccine Live
• February 27, 2023 Clinical Review Memo - Measles, Mumps, and Rubella Virus Vaccine Live
• Statistical Review - Measles, Mumps, and Rubella Virus Vaccine Live
• December 11, 2020 Approval Letter - Measles, Mumps, and Rubella Virus Vaccine Live
• June 19, 2020 Approval Letter - Measles, Mumps, and Rubella Virus Vaccine Live
• May 16, 2017 Approval Letter - Measles, Mumps, and Rubella Virus Vaccine Live
• Supporting Documents older than three years - MMR II